Whether we start from mid-December 2019 or mid-February, 2020, the amount of new information is increasingly rapid. With in a remarkably short time, so much is being learned about the disease that it must now be called a disease spectrum. Of course the primary end-organ affected is the ACE2 receptor bearing lungs.